V. Matt Laurich, MD

Director, Fellowship Program – University of Connecticut School of Medicine | Pediatric Emergency Medicine Physician

V. Matt Laurich, MD, is an Emergency Medicine Physician in the Emergency Department at Connecticut Children’s in Hartford. His clinical and research interests include the febrile young infant and pediatric sepsis and septic shock. Dr. Laurich completed his residency in Pediatrics at Morgan Stanley Children’s Hospital of New York-Presbyterian at Columbia University Medical Center in 2008. He then completed his fellowship in Pediatric Emergency Medicine at Mount Sinai Hospital in New York City in 2011. During fellowship, Dr. Laurich’s research focused on the use of bedside ultrasound to evaluate first-trimester pregnancy complications in pregnant adolescents.

Education

University of Pennsylvania School of Medicine

Residency

Columbia University Irving Medical Center

Fellowship

Mount Sinai Hospital

American Board of Pediatrics - Emergency Medicine
American Board of Pediatrics - Pediatrics

Associate Professor of Pediatrics, University of Connecticut School of Medicine

  • Laurich VM, Tsung JW. Point of Care First Trimester Pelvic Ultrasonography for the Pediatric Emergency Physician. Clin Ped Emerg Med. 2011, 12(1): 18-26.
  • Newland JG, Laurich VM, Rosenquist AW, Heydon K, Licht DJ, Keren R, Zaoutis TE, Watson B, Hodinka RL, Coffin SE. Neurologic Complications in Children Hospitalized with Influenza: Characteristics, Incidence, and Risk Factors. J Peds. 2007; 150(3):306-310.
  • Laurich VM, Trbovich AM, O’Neill FH, Houk CP, Sluss PM, Payne AH, Donahoe PK, Teixeira J. Mullerian inhibiting substance blocks the protein kinase A-induced expression of cytochrome p450 17alpha-hydroxylase/C(17-20) lyase mRNA in a mouse Leydig cell line independent of cAMP responsive element binding protein phosphorylation. Endocrinol. 2002; 143(9):3351-3360.
  • Lorenzo HK, Teixeira J, Pahlavan N, Laurich VM, Donahoe PK, MacLaughlin DT. New approaches for high-yield purification of Mullerian inhibiting substance improve its bioactivity. J Chromatogr B. 2002; 766(1):89-98.
  • Trbovich AM. Sluss PM. Laurich VM. O’Neill FH. MacLaughlin DT. Donahoe PK. Teixeira J. Mullerian Inhibiting Substance lowers testosterone in luteinizing hormone-stimulated rodents. Proc Natl Acad Sci USA. 2001; 98(6):3393-3397.

Dr. Laurich is director of the Pediatric Emergency Medicine Fellowship Program at the University of Connecticut School of Medicine.